, 98 patients underwent breast reconstruction with tissue from the lower abdomen. In 24 patients, the reconstruction was bilateral. With the aid of a prospectively maintained database, all morbidity-reducing measures were analyzed and an algorithm was created.
CONCLUSION:
The lower abdomen constitutes unequivocally the gold standard as the donor choice in autologous breast reconstruction. By implementing technical modifications in dealing with the donor site as well as the recipient site, overall morbidity may be reduced significantly. The meaningful adoption of these techniques will lead to a quicker postoperative recovery with no expenses on safety and the aesthetic result.
EFFECT OF MONTELUKAST ON CAPSULAR CONTRACTURE AFTER BREAST AUGMENTATION: A COMPARATIVE STUDY

Salvatore Giordano, FINLAND
BACKGROUND: Leukotriene antagonists zafirlukast and montelukast have been used by plastic surgeons off-label to prevent and treat capsular contracture in breast implant surgery. At the present, only few studies investigated their efficacy.
METHODS:
A retrospective analysis was performed to investigate the effectiveness of montelukast in preventing and treating capsular contracture.
This study included 177 consecutive women who underwent cosmetic breast surgery using textured silicone prostheses.
Same surgeon operated all women using inframammary approach and dual-plane pocket and a treatment of at least 3 months of montelukast was offered to them at the regimen of 20mg once a day. Therefore, patients were divided into two groups on the basis of montelukast treatment.
Follow-up on montelukast efficacy was obtained by a combination of office chart review and strandardized telephone questionnaire with a minimum follow-up of 4 years.
RESULTS:
Sixty-seven patients received montelukast for 3-6 months. Mean age of the patients was 35.82 ± 8.71 years (range 19-56 years), and co-morbidity was present in 11.76% of cases. All groups combined had a mean follow-up evaluation of 58.71 ± 13.45 months (range 48-136 months) and mean breast size (cc) of 333.89 ± 107.60 cc (range 155-690 cc).
No significant differences were found for the use of montelukast versus control in the prevention of capsular contracture after surgery, although the number of affected patients and the severity of capsular contracture were higher among the patients who did not use montelukast. No adverse effects were found.
CONCLUSIONS:
Montelukast may prevent and improve symptoms of capsular contracture. However, further studies are needed for justifying its somministration.
REGENERATIVE PLASTIC SURGERY IN POSTMASTECTOMY BREAST RECONSTRUCTION -EVOLUTION OF THE CONCEPT REFLECTED IN CURRENT PERSONAL PRACTICE
Dana Jianu, Oltjon Cobani, Ioana Ghiurco, Marian Turbatu, Mihaela Vartic, ROMANIA BACKGROUND: The concept to restore the breast postmastectomy through regenerative surgery with fat tissue and implants or to regenerate it solely with fat tissue and reverse expansion (RE) is not new but still a rare procedure.
